<html><head><title>2024-04-13</title><link rel="stylesheet" type="text/css" href="static/table.css"/></head><body><table id="container">
  <thead>
    <tr style="text-align: right;">
      <th role="columnheader">No.</th>
      <th role="columnheader">capSize</th>
      <th role="columnheader">stock</th>
      <th role="columnheader">chance</th>
      <th role="columnheader">risk</th>
      <th role="columnheader">tags</th>
      <th role="columnheader">Volatility</th>
      <th role="columnheader">YTD%</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>1</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/NEM">NEM<br>Newmont</a></td>
      <td>1. Newmont Corporation (NEM) concluded the recent trading session at $38.64, signifying a -1.1% move from its prior day's close.<br>2. Gold declined after surging to a fresh record as investors booked profit in a price rally that’s seen as overextended.<br>3. The latest trading day saw Newmont Corporation (NEM) settling at $39.06, representing a -1.54% change from its previous close.<br>4. Gold dipped after Wednesday’s stronger than expected inflation report, but recovered throughout the day and may be ready to extend its rally.<br>5. **Blackberry (BB)**, **(CA:BB)**: The company's stock rose after it announced a robotics-systems partnership with chipmaking giant Advanced Micro Devices (AMD).<br>6. The world’s biggest gold miners are at risk of missing out on the metal’s record run after spending billions of dollars to become the obvious home for bullion-focused investors.</td>
      <td>1. Most Read from BloombergIsrael Bracing for Unprecedented Direct Iran Attack in Days<br>2. Stocks Get Hit as War Jitters Fuel Rush to Bonds: Markets Wrap<br>3. Investors may be buying gold as a stock market hedge due to concerns that economic growth will decelerate due to prolonged high interest rates.<br>4. Global tensions are another reason investors may be hedging.</td>
      <td>Gold<br>Mining<br>Investing<br>Market Trends</td>
      <td>246.44</td>
      <td>9.28</td>
    </tr>
    <tr>
      <td>2</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/DOC">DOC<br>nan</a></td>
      <td>1. Healthpeak Properties, Inc. is a leading owner, operator, and developer of real estate for healthcare discovery and delivery, indicating potential growth opportunities in the healthcare real estate sector.<br>2. The merger with Physicians Realty Trust positions Healthpeak well to capitalize on secular trends in the industry, providing a potential boost to its financial performance.</td>
      <td>1. The decrease in net income while revenue grows raises concerns about the company’s profitability and efficiency.</td>
      <td>Healthcare Real Estate<br>Merger<br>Financial Performance<br>Profitability<br>Secular Trends</td>
      <td>687.19</td>
      <td>0.00</td>
    </tr>
    <tr>
      <td>3</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/YMM">YMM<br>Full Truck Alliance</a></td>
      <td>1. Full Truck Alliance Co., Ltd. operates as a holding company that provides comprehensive services for shippers and truckers through its mobile and website platforms.<br>2. The company's platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights and types.<br>3. Full Truck Alliance was founded by Hui Zhang in 2011 and is headquartered in Guiyang, China.<br>4. The company offers drivers other services such as financing and insurance, as well as selling fuel cards and secondhand trucks.</td>
      <td>1. The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so caution is advised.<br>2. Given the large stake in the stock by institutions, Full Truck Alliance's stock price might be vulnerable to market fluctuations.</td>
      <td>Logistics<br>Digital Freight<br>Emerging Markets<br>Investing<br>Trucking</td>
      <td>376.04</td>
      <td>22.19</td>
    </tr>
    <tr>
      <td>4</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/RTX">RTX<br>RTX</a></td>
      <td>1. RTX has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.<br>2. 2024 could be a better year for this aerospace and defense company if the analyst's projections hold true.</td>
      <td>1. Despite all the doom and gloom, the stock still has a value case, and the company's strategy makes sense.</td>
      <td>Aerospace<br>Defense<br>Earnings Surprise<br>Growth Potential<br>Modernization</td>
      <td>335.19</td>
      <td>9.30</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/BTG">BTG<br>B2Gold</a></td>
      <td>1. Mali's industrial gold output is expected to drop by about 14% this year, which may affect B2Gold Corp's operations in the region.<br>2. Gold prices have surged recently and are trading at near all-time highs, presenting a positive opportunity for B2Gold Corp.<br>3. The best dividend stocks, like B2Gold Corp, can produce steady returns from both quarterly payouts and long-term price appreciation.</td>
      <td>1. In an ecosystem of high interest rates, targeting high-yield dividend stocks like B2Gold Corp might seem risky.<br>2. The close of 2023 saw a surge in gold prices, but the market environment for gold and other precious metals stocks may be uncertain.</td>
      <td>Gold<br>Mining<br>Dividend Stocks<br>Mali<br>Market Environment</td>
      <td>333.58</td>
      <td>3.21</td>
    </tr>
    <tr>
      <td>6</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/MRK">MRK<br>Merck &</a></td>
      <td>1. Merck's (MRK) stock has shown a 7.0% increase over the past three months, indicating positive growth potential.<br>2. Early-stage study data shows positive clinical response for Moderna's (MRNA) experimental cancer therapy, potentially boosting the healthcare industry.<br>3. Merck (MRK) has initiated a Phase 3 clinical trial for its investigational oral selective KRAS G12C inhibitor, indicating a strong pipeline for future growth.</td>
      <td>1. Merck (MRK) has weak financial performance indicators, suggesting potential risks for investors.<br>2. The healthcare industry faces uncertainties, and the success of experimental therapies is not guaranteed.<br>3. Market volatility and regulatory uncertainties may impact the performance of healthcare stocks such as Merck (MRK).</td>
      <td>Healthcare<br>Pharmaceuticals<br>Clinical Trials<br>Stock Market<br>Investing</td>
      <td>443.05</td>
      <td>0.10</td>
    </tr>
    <tr>
      <td>7</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/DELL">DELL<br>Dell</a></td>
      <td>1. Dell Technologies has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.<br>2. Dell Technologies is riding on a robust portfolio and an expanding network of partners that is expected to drive top-line growth.<br>3. The PC and server maker is still a stable long-term investment.</td>
      <td>1. The company has strong AI-led operations, but a very weak balance sheet.<br>2. The stock has outperformed Apple over the past five years, but future performance is uncertain.<br>3. Dividend-paying stocks from the technology sector may not always be reliable.</td>
      <td>Technology<br>Stocks<br>Investment<br>Earnings prospects<br>AI</td>
      <td>619.54</td>
      <td>37.28</td>
    </tr>
    <tr>
      <td>8</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/META">META<br>Meta Platforms</a></td>
      <td>1. Meta Platforms is testing Meta AI with WhatsApp, Instagram, and Messenger users in India and parts of Africa, indicating the company's plans to scale its AI offerings across its various apps.<br>2. META has unveiled next-generation custom-made chips to address the needs of its expanding AI workloads, showcasing the company's commitment to technological advancement.<br>3. The company's decision to lower the minimum age required to use WhatsApp in Europe to 13 from 16 could potentially expand its user base and drive further engagement.<br>4. Meta's innovative AI solutions make it an attractive choice for investors eyeing the AI market in 2024.<br>5. The insider sale reported by Meta Platforms Inc could be an important factor to consider in analyzing the company's stock performance.</td>
      <td>1. Facing criticism from children's rights advocates for lowering the minimum age to use WhatsApp, Meta Platforms may encounter regulatory challenges and public backlash.<br>2. The discontinuation of Andrew Forrest's criminal prosecution of Meta Platforms over scam cryptocurrency advertisements could impact the company's reputation and legal standing.<br>3. The development of in-house AI chips by major tech companies like Alphabet, Amazon, and Microsoft could pose a threat to Meta Platforms' dependency on NVIDIA's hardware.<br>4. The ongoing civil lawsuit against Meta Platforms over scam cryptocurrency advertisements may lead to potential legal liabilities and financial implications for the company.</td>
      <td>AI<br>User Engagement<br>Regulatory Challenges<br>Legal Liabilities<br>Stock Performance</td>
      <td>380.45</td>
      <td>29.83</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/CPNG">CPNG<br>Coupang</a></td>
      <td>1. Coupang (NYSE:CPNG) stock broke out and jumped 11.4% in the afternoon session after the company announced it would raise its WOW membership by 58%<br>2. Significantly high institutional ownership implies Coupang's stock price is sensitive to their trading<br>3. Earnings results often give us a good indication of what direction a company will take in the months ahead</td>
      <td>1. Coupang shares remain down more than 60% from their initial public offering price<br>2. The post-pandemic era witnessed significant readjustments in terms of shifting back to shopping in physical stores<br>3. There were revisions on the downside for some of the major e-commerce players</td>
      <td>E-commerce<br>Stock Analysis<br>Investing<br>Retail<br>Membership Program</td>
      <td>248.52</td>
      <td>52.77</td>
    </tr>
    <tr>
      <td>10</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/GERN">GERN<br>Geron</a></td>
      <td>1. Geron Corporation is developing a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies, which shows promising prospects in the field of oncology.<br>2. The FDA's potential expansion of the use of multiple myeloma cell therapies and other top-selling medicines indicates a favorable regulatory environment for Geron Corporation's products.</td>
      <td>1. The company recently conducted an underwritten offering, which might indicate a need for additional funding or potential dilution of shares.<br>2. The biopharmaceutical industry is highly competitive, and success is dependent on regulatory approvals and clinical trial results.</td>
      <td>Biotechnology<br>Oncology<br>Telomerase Inhibitor<br>FDA Regulation<br>Clinical Trials</td>
      <td>706.82</td>
      <td>89.58</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/PBR">PBR<br>nan</a></td>
      <td>1. Petrobras is leveraging advanced technology to discover oil in Brazil's unexplored Potiguar Basin, marking a new frontier for the company.<br>2. Zacks.com users have been paying close attention to Petrobras, indicating potential investor interest.<br>3. The recent +1.53% shift from the previous trading day suggests some positive momentum for Petrobras.<br>4. The company engages in oil and gas exploration, production, and distribution activities, indicating potential for growth in the energy sector.</td>
      <td>1. A Brazilian judge has suspended the chair of Petrobras' board over a conflict of interest, leading to uncertainty in the company's leadership.<br>2. Speculation about replacing Petrobras CEO adds uncertainty to the company's future direction.<br>3. The ruling against the chair of Petrobras' board could lead to further legal and governance issues for the company.<br>4. The company's operations are subject to the volatile nature of the oil and gas market.</td>
      <td>Oil & Gas<br>Exploration<br>Brazil<br>Leadership<br>Market Volatility</td>
      <td>371.90</td>
      <td>-10.12</td>
    </tr>
    <tr>
      <td>12</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/AES">AES<br>The AES</a></td>
      <td>1. AES has shown strong financial resilience and growth, beating earnings estimates in the fourth quarter of 2023.<br>2. The completion of 3.5 GW of renewables indicates the company's commitment to sustainable energy.<br>3. Favorable earnings estimate revision activity and positive Zacks Earnings ESP heading into earnings season are positive indicators for AES.</td>
      <td>1. The stock may face challenges in overcoming the impact of cost of sales and operating activities on its cash flow.<br>2. Uncertainties in the market and potential negative trends in the stock performance pose a risk to investors.<br>3. Fluctuations in the market may impact AES' market position and future prospects.</td>
      <td>Earnings<br>Renewable Energy<br>Market Performance<br>Financial Resilience<br>Sustainable Growth</td>
      <td>262.97</td>
      <td>-1.81</td>
    </tr>
    <tr>
      <td>13</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/AZN">AZN<br>AstraZeneca</a></td>
      <td>1. FDA approval for AstraZeneca's Fasenra for severe asthma in younger patients indicates potential for increased market share and revenue growth.<br>2. AstraZeneca's continued focus on research and development of new treatments is a positive sign for future innovation and expansion.<br>3. AstraZeneca's strong performance in the recent trading session indicates investor confidence and potential for further stock price growth.</td>
      <td>1. Investor backlash over CEO's high pay award may lead to negative sentiment and potential impact on stock performance.<br>2. Continued discontent among investors regarding high executive pay may create uncertainty and instability for AstraZeneca.<br>3. Concerns about a 'sluggish and disappointing decade' for global economic growth may create challenges for pharmaceutical companies like AstraZeneca.</td>
      <td>FDA approval<br>Investor backlash<br>Market performance<br>Innovation focus<br>Global economic growth</td>
      <td>349.34</td>
      <td>4.61</td>
    </tr>
    <tr>
      <td>14</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/BILI">BILI<br>Bilibili</a></td>
      <td>1. Bilibili Inc. continues to show growth potential, with a 2.9% increase in revenue for the full year 2023.<br>2. The company's focus on live streaming and content creator commercialization indicates a strategic shift to drive profitability.</td>
      <td>1. Bilibili's struggle to make a profit in the live streaming business poses a risk to long-term investor confidence.<br>2. The high risk tolerance required to pursue aggressive stocks to achieve 10X returns may not suit all investors.</td>
      <td>Video Streaming<br>Chinese Market<br>Financial Performance<br>Risk Management<br>Strategic Shift</td>
      <td>282.79</td>
      <td>22.78</td>
    </tr>
    <tr>
      <td>15</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/MU">MU<br>Micron Technology</a></td>
      <td>1. Micron Technology Inc's introduction of the groundbreaking 4150AT SSD and qualification of automotive memory and storage solutions for Qualcomm customers reflect potential growth opportunities in the automotive and intelligent vehicle market.<br>2. The company's AI-driven surge and virtualized, multiport 4150AT SSD may lead to a long-lasting uptrend in the memory chip market.<br>3. Qualifying a full suite of automotive-grade memory and storage solutions for Qualcomm's Snapdragon Digital Chassis shows Micron's commitment to catering to the evolving needs of intelligent vehicles.</td>
      <td>1. The April 3 earthquake in Taiwan is expected to reduce Micron's DRAM supply for the calendar quarter by up to a mid-single-digit percentage, which may impact the company's production capacity and potential disruptions in the global chip supply chain.<br>2. Although quarterly earnings results provide insight into the company's progress, there are concerns about the potential impact of the earthquake on Micron's DRAM supply.<br>3. Tech stocks, including Micron, are patiently waiting for potential catalysts before making their next move, indicating a degree of uncertainty in the market.</td>
      <td>Chip stocks<br>Automotive market<br>Memory chip market<br>Tech stocks<br>Global supply chain disruptions</td>
      <td>290.99</td>
      <td>43.30</td>
    </tr>
    <tr>
      <td>16</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/KDP">KDP<br>Keurig Dr Pepper</a></td>
      <td>1. Keurig Dr Pepper (KDP) is on a growth track, with a focus on brand strength, innovation efforts, resilient category trends, market share gains, and significant pricing actions.<br>2. The company has a strong position in the non-alcoholic beverages market, with a wide range of popular brands including Dr Pepper, Canada Dry, Snapple, A&W, 7UP, and more.<br>3. The upcoming leadership transition with Tim Cofer taking over as CEO brings potential for new growth strategies and market expansion.</td>
      <td>1. The recent performance of Keurig Dr Pepper's stock may be a cause for concern, with potential risks in the current business environment and competition in the beverages and alcohol industry.<br>2. The company's dividend performance and sustainability may need to be closely monitored, especially with the upcoming dividend payment and CEO transition.<br>3. There may be challenges in maintaining and expanding market share, as well as addressing changing consumer preferences in the non-alcoholic beverages segment.</td>
      <td>Beverages<br>Non-alcoholic<br>Market share<br>Competition<br>Leadership transition</td>
      <td>297.26</td>
      <td>-4.88</td>
    </tr>
    <tr>
      <td>17</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/KOS">KOS<br>Kosmos Energy</a></td>
      <td>1. Kosmos Energy has a strong exploration and production portfolio, with assets in offshore Ghana, Equatorial Guinea, U.S. Gulf of Mexico, and Mauritania and Senegal.<br>2. The company maintains a sustainable exploration program, balancing between proven basin infrastructure-led exploration, emerging basins, and frontier basins.</td>
      <td>1. The contracts of oil and gas projects developed by Kosmos Energy may be revisited by the newly elected Senegalese President, which could potentially impact the company's revenue.<br>2. The addition of $350 million aggregate principal amount of 3.125% convertible senior notes due 2030 and the option to purchase an additional $50 million aggregate principal amount of notes may increase the company's debt burden.</td>
      <td>Oil and Gas<br>Exploration<br>Production<br>Offshore Assets<br>Debt Offering</td>
      <td>292.64</td>
      <td>4.03</td>
    </tr>
    <tr>
      <td>18</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/ETRN">ETRN<br>Equitrans Midstream</a></td>
      <td>1. EQT's acquisition of Equitrans Midstream for $5.5 billion unveils the CEO's vision for AI-driven growth.<br>2. Equitrans is the majority owner of a pipeline situated in one of the fastest growing AI data center hubs.<br>3. The crypto exchange rose nearly 4%, as bitcoin notched another record high.</td>
      <td>1. Shares of EQT are having one of their worst days in two years and leading the S&P 500 lower after the natural-gas producer said it would buy back the pipeline operator that it had spun off in 2018.<br>2. EQT Corp. plans to acquire Equitrans Midstream with $5.5 billion equity, but will assume debt of $7.6 billion or more in the process, while likely facing intense regulatory scrutiny.</td>
      <td>Stock Acquisition<br>AI-driven Growth<br>Cryptocurrency<br>Debt<br>Regulatory Scrutiny</td>
      <td>581.87</td>
      <td>23.04</td>
    </tr>
  </tbody>
</table><script src="static/tablesort.min.js"></script><script src="static/tablesort.number.min.js"></script><script>new Tablesort(document.getElementById("container"));</script></body></html>